Back

Cardiotoxicity in Ewing- and osteosarcoma: a 40 year experience from a tertiary sarcoma center

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardio-oncology revisited Cardio-Oncology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Julius Heemelaar

Alrijne Hospital Leiderdorp, Leiderdorp (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors
Doctor D. Laenens (Mechelen, BE)
Abstract Slides Video
Presentation thumbnail
HFA-ICOS cardiovascular toxicity risk score validation in CARDIOTOX registry
Doctor B. Rivero Santana (Madrid, ES) Doctor A. Severo (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
High risk of cardiovascular disease in curatively treated patients with oesophageal cancer: a danish cohort study
Doctor M. Soendergaard (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Mortality and major adverse cardiac events in women with breast cancer receiving radiotherapy: a 10-year cohort study of patients and population controls
Doctor J. Jacobs (Leuven, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology revisited

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Reversing the damage: imaging-guided therapy in a case of severe cardiotoxicity
thumbnail
Congress Presentation
Case 2 - delayed heart failure diagnosis in a cancer survivor: the cost of lost surveillance and the challenge on Maltese healthcare
thumbnail
Congress Presentation
Long term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources